|
|
|
Si bone inc (NASDAQ: SIBN) |
|
|
|
| |
Si bone inc Outlook |
On February 24 2025 the Si bone inc provided following guidance
nnSI-BONE, Inc. Announces Exceptional Financial Performance for Q4 2024 and Provides Forward-Looking Guidance for 2025nn
SI-BONE, Inc. has reported remarkable financial achievements for the fourth quarter of 2024, showcasing a substantial 26% increase in global revenue year-over-year alongside a positive adjusted EBITDA. This impressive growth underscores the company's effective strategies and robust market position.
While the company has shared its outlook for 2025, specific details regarding the financial guidance remain undisclosed. Investors and s alike will be keenly awaiting further elaboration on projected figures and financial metrics as the year progresses.
The fourth quarter results highlight SI-BONE's successful execution of its business plan and strong demand for its innovative solutions. The positive adjusted EBITDA reflects the company's ongoing commitment to operational efficiency and profitability.
Given the favorable financial momentum experienced in Q4 2024, SI-BONE, Inc. is poised for continued growth into 2025, further building on its strong foundation.,
|
On August 5 2024 the Si bone inc provided following guidance
nnSI-BONE, Inc. Financial Performance Update for the Second Quarter of 2024nn
SI-BONE, Inc. has announced its financial outcomes for the second quarter of 2024, along with an optimistic update on its revenue expectations for the year. The company has raised its revenue forecast for 2024, now anticipating that total revenues will be between $165 million and $167 million. This upward revision reflects confidence in the company's growth trajectory and market demand for its products.
Moreover, SI-BONE is projecting a significant milestone, stating that it expects to achieve positive Adjusted EBITDA in the fourth quarter of 2024. This marks a notable point in the company's financial strategy as it aims to enhance profitability and operational efficiency.
nnUpdated 2024 Revenue Forecast: $165 million - $167 millionnn
nnAnticipation of Positive Adjusted EBITDA in Q4 2024nn
|
On May 6 2024 the Si bone inc provided following guidance
SI-BONE, Inc. has announced its financial results for the first quarter of 2024, revealing impressive growth and strong performance. The company has increased its annual guidance to a range of $164 million to $166 million, indicating a substantial annual growth rate of approximately 18% to 20%.
This updated guidance reflects the continued success and momentum of SI-BONE, Inc. as it continues to expand its reach and impact in the medical industry. The company's leadership is optimistic about its prospects for the rest of the year, confident in its ability to sustain and build upon its current growth trajectory. Investors and stakeholders can look forward to sustained profitability and success from SI-BONE, Inc. as it forges ahead in its mission to improve patient outcomes and revolutionize the field of orthopedic medicine.
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.
